Breast Cancer Clinical Trial
Official title:
Developing and Testing a Tamoxifen Prophylaxis Decision Aid
RATIONALE: Evaluating a decision aid that describes the risks and benefits of taking
tamoxifen citrate to prevent breast cancer may be helpful for women at increased risk of
breast cancer.
PURPOSE: This randomized phase I/II trial is studying tamoxifen citrate decision aids for
women at increased risk of breast cancer.
OBJECTIVES:
- To develop and test a decision aid for describing the risks and benefits of taking
tamoxifen citrate to prevent primary breast cancer in women at increased risk of breast
cancer.
OUTLINE:
- Phase I: Patients are randomized to view 1 of 16 decision aids that vary in terms of
how the information is presented based on 5 dimensions: 1) statistical information in
pictographs vs plain text, 2) risk information presented with denominators of 100 vs
1000, 3) risk information presented in terms of total vs additional risk, 4) whether
the risks of tamoxifen citrate are presented before or after the benefits are
presented, and 5) contextual information about other risks the patient faces (all cause
mortality, colon cancer, heart attack).
Patients complete baseline and post-test questionnaires.
- Phase II: Patients are randomized to 1 of 3 arms.
- Arm I (control): Patients do not view the decision aid, but complete baseline and
post-test questionnaires.
- Arm II (control): Patients complete a baseline questionnaire only. They do not
view the decision aid or complete the post-test questionnaire.
- Arm III (intervention): Patients view 1 of 16 decision aids that vary based on 5
factors: 1) providing (or not) comparative information about the average woman's
breast cancer risk, 2) sequencing presentation of risks and benefits (risks first
vs benefits first), 3) including (or not) a summary table following presentation
of risks and benefits, 4) using second vs third person language ("your risk" vs "a
person like you"), and 5) presenting the decision as having 2 vs 3 options
(taking/not taking a breast cancer prevention drug vs taking tamoxifen
citrate/raloxifene, or no drug). Patients also complete baseline and post-test
questionnaires.
Patients in both phases complete an online follow-up survey at 3 months. Patients in arms I
or II (of phase II) receive a decision aid after completion of the follow-up survey.
;
Allocation: Randomized
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |